Curated News
By: NewsRamp Editorial Staff
September 15, 2026
OMRON Marks 40 Years of Ohasama Study for World Heart Day
TLDR
- OMRON Healthcare leverages 40 years of Ohasama Study data to lead in home blood pressure monitoring and preventive cardiovascular care.
- The Ohasama Study tracked over 11,000 residents for 15 years, proving home blood pressure measurements predict cardiovascular outcomes better than clinic readings.
- The Ohasama Study's 40-year collaboration has improved global hypertension management, helping people live longer and healthier lives.
- A 40-year study in Japan showed that measuring blood pressure at home is a stronger predictor of heart health than clinic readings.
Impact - Why it Matters
The Ohasama Study's 40-year legacy has fundamentally changed how hypertension is managed worldwide. By proving that home blood pressure readings are stronger predictors of cardiovascular outcomes than clinic measurements, it empowered individuals to take control of their heart health and gave healthcare professionals a more accurate tool for diagnosis and treatment. This shift has likely contributed to reduced rates of stroke, heart attack, and other cardiovascular events. As cardiovascular disease remains the leading cause of death globally, the study's ongoing research into early biomarkers and preventive strategies offers hope for even earlier interventions. OMRON's continued commitment to preventive care, including atrial fibrillation detection, means that patients and families can benefit from innovations that save lives. Ultimately, this milestone is a testament to the power of long-term collaboration and evidence-based innovation in improving public health.
Summary
OMRON Healthcare Co., Ltd., a global leader in clinically proven medical equipment for home health monitoring, is celebrating the 40th anniversary of the Ohasama Study, one of the world's longest-running community-based cardiovascular research projects. Launched in 1986 by a team from Tohoku University under Professor Yutaka Imai, the study was a response to the high burden of hypertension and stroke in Ohasama, Iwate Prefecture. OMRON supported the study from the outset by providing some 300 home blood pressure monitors, forging a partnership that continues today. The study followed more than 11,000 residents over an average of 15 years, demonstrating that home blood pressure measurement is a stronger predictor of cardiovascular outcomes than in-clinic readings alone. This evidence helped establish the internationally recognized 135/85 mmHg home blood pressure threshold and influenced guidelines from the World Health Organization and the European Society of Hypertension, making home monitoring a routine part of hypertension diagnosis and management.
Now led by Professor Takayoshi Ohkubo as a multicentre collaborative study coordinated by Teikyo University in Tokyo, the Ohasama Study continues to generate new insights. Recent findings include an association between a higher urinary sodium-to-potassium ratio and elevated BNP levels, a biomarker of cardiac load, suggesting potential for earlier identification of cardiac stress. Dr. Imai praised the long-term cooperation of local residents, healthcare professionals, government officials, and researchers, noting that the people of Ohasama helped build the scientific evidence for home blood pressure measurement. Ayumu Okada, President and CEO of OMRON Healthcare, emphasized the company's commitment to its Going for Zero vision, which aims to eliminate adverse cerebro- and cardiovascular events through preventive care.
As cardiovascular disease remains the world's leading cause of death, OMRON continues to advance preventive cardiovascular care through initiatives such as promoting regular home blood pressure measurement and earlier detection of atrial fibrillation. The company has sold over 400 million home blood pressure monitors globally and provides products and services in more than 130 countries. This milestone, announced ahead of World Heart Day on September 29, underscores the enduring impact of the Ohasama Study on global hypertension management. For more information, visit the OMRON Healthcare website.
Source Statement
This curated news summary relied on content distributed by NewMediaWire. Read the original source here, OMRON Marks 40 Years of Ohasama Study for World Heart Day
